251 related articles for article (PubMed ID: 25790815)
1. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma.
Khanna M; Ramanathan S; Fasih N; Schieda N; Virmani V; McInnes MD
Insights Imaging; 2015 Jun; 6(3):347-62. PubMed ID: 25790815
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation.
Sousa CMN; Gadelha PMM; Cartaxo RS; Pedrosa GWH; Honorio RS; Lima JMC; Coelho GR; Coelho CR
Case Rep Gastroenterol; 2017; 11(3):637-642. PubMed ID: 29282384
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
4. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
6. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
[TBL] [Abstract][Full Text] [Related]
8. [Focal nodular hyperplasia and hepatocellular adenoma].
Bastati-Huber N; Pötter-Lang S; Ba-Ssalamah A
Radiologe; 2015 Jan; 55(1):18-26. PubMed ID: 25575723
[TBL] [Abstract][Full Text] [Related]
9. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
10. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma.
Krause K; Tanabe KK
Ann Surg Oncol; 2020 Sep; 27(9):3330-3338. PubMed ID: 32542565
[TBL] [Abstract][Full Text] [Related]
11. Imaging of benign hepatocellular lesions: current concepts and recent updates.
Ronot M; Vilgrain V
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):681-8. PubMed ID: 24636468
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma: what is new in 2008.
Bioulac-Sage P; Laumonier H; Laurent C; Zucman-Rossi J; Balabaud C
Hepatol Int; 2008 Sep; 2(3):316-21. PubMed ID: 19669260
[TBL] [Abstract][Full Text] [Related]
15. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Adenomatosis in a Young Asymptomatic but High-risk Patient: An Incidental Diagnosis with Potentially Severe Clinical Implications.
Lanza D; Bilali M
Eur J Case Rep Intern Med; 2021; 8(11):002999. PubMed ID: 34912742
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI.
Michallek F; Sartoris R; Beaufrère A; Dioguardi Burgio M; Cauchy F; Cannella R; Paradis V; Ronot M; Dewey M; Vilgrain V
Insights Imaging; 2022 Apr; 13(1):81. PubMed ID: 35482151
[TBL] [Abstract][Full Text] [Related]
18. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update.
Tse JR; Felker ER; Naini BV; Shen L; Shen J; Lu DSK; Kamaya A; Raman SS
Radiographics; 2023 Mar; 43(3):e220134. PubMed ID: 36821508
[TBL] [Abstract][Full Text] [Related]
20. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Tse JR; Naini BV; Lu DS; Raman SS
Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
